1932 related articles for article (PubMed ID: 28898808)
1. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
[TBL] [Abstract][Full Text] [Related]
2. Interstate data sharing of prescription drug monitoring programs and associated opioid prescriptions among patients with non-cancer chronic pain.
Lin HC; Wang Z; Simoni-Wastila L; Boyd C; Buu A
Prev Med; 2019 Jan; 118():59-65. PubMed ID: 30316875
[TBL] [Abstract][Full Text] [Related]
3. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
[TBL] [Abstract][Full Text] [Related]
5. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
6. Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery.
Stucke RS; Kelly JL; Mathis KA; Hill MV; Barth RJ
JAMA Surg; 2018 Dec; 153(12):1105-1110. PubMed ID: 30140927
[TBL] [Abstract][Full Text] [Related]
7. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.
Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF
J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747
[TBL] [Abstract][Full Text] [Related]
8. Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012.
Perrone J; DeRoos FJ; Nelson LS
J Med Toxicol; 2012 Dec; 8(4):341-52. PubMed ID: 22895794
[TBL] [Abstract][Full Text] [Related]
9. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
Martello J; Cassidy B; Mitchell A
J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
[TBL] [Abstract][Full Text] [Related]
10. Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.
Bao Y; Pan Y; Taylor A; Radakrishnan S; Luo F; Pincus HA; Schackman BR
Health Aff (Millwood); 2016 Jun; 35(6):1045-51. PubMed ID: 27269021
[TBL] [Abstract][Full Text] [Related]
11. Prescription Drug Monitoring Programs Produce a Limited Impact on Painkiller Prescribing in Medicare Part D.
Yarbrough CR
Health Serv Res; 2018 Apr; 53(2):671-689. PubMed ID: 28101955
[TBL] [Abstract][Full Text] [Related]
12. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
[TBL] [Abstract][Full Text] [Related]
13. Variations in prescription drug monitoring program use by prescriber specialty.
Sun BC; Lupulescu-Mann N; Charlesworth CJ; Kim H; Hartung DM; Deyo RA; John McConnell K
J Subst Abuse Treat; 2018 Nov; 94():35-40. PubMed ID: 30243415
[TBL] [Abstract][Full Text] [Related]
14. The effects of state rules on opioid prescribing in Indiana.
Al Achkar M; Grannis S; Revere D; MacKie P; Howard M; Gupta S
BMC Health Serv Res; 2018 Jan; 18(1):29. PubMed ID: 29347984
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of statewide prescription drug monitoring programs and potentially inappropriate opioid prescribing to patients with non-cancer chronic pain: A machine learning application.
Lin HC; Wang Z; Hu YH; Simon K; Buu A
Prev Med; 2022 Aug; 161():107116. PubMed ID: 35750263
[TBL] [Abstract][Full Text] [Related]
16. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes.
Nielsen S; Picco L; Russell G; Pearce C; Andrew NE; Lubman DI; Bell JS; Buchbinder R; Xia T
Int J Drug Policy; 2023 Jul; 117():104053. PubMed ID: 37209441
[TBL] [Abstract][Full Text] [Related]
17. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
Manders L; Abd-Elsayed A
Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
[TBL] [Abstract][Full Text] [Related]
18. Opioid prescribing patterns for non-malignant chronic pain for rural versus non-rural US adults: a population-based study using 2010 NAMCS data.
Prunuske JP; St Hill CA; Hager KD; Lemieux AM; Swanoski MT; Anderson GW; Lutfiyya MN
BMC Health Serv Res; 2014 Nov; 14():563. PubMed ID: 25407745
[TBL] [Abstract][Full Text] [Related]
19. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
[TBL] [Abstract][Full Text] [Related]
20. Prescription Drug Monitoring Program Use: National Dental PBRN Results.
McCauley JL; Gilbert GH; Cochran DL; Gordan VV; Leite RS; Fillingim RB; Brady KT;
JDR Clin Trans Res; 2019 Apr; 4(2):178-186. PubMed ID: 30931705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]